BioPharma Credit PLC Price Chart
BioPharma Credit PLC B3P.MU Financial and Trading Overview
BioPharma Credit PLC stock price | 0.75 EUR |
Previous Close | 0.82 EUR |
Open | 0.81 EUR |
Bid | 0.81 EUR x 0 |
Ask | 0.89 EUR x 0 |
Day's Range | 0.81 - 0.81 EUR |
52 Week Range | 0.81 - 0.81 EUR |
Volume | 500 EUR |
Avg. Volume | N/A |
Market Cap | 1.15B EUR |
Beta (5Y Monthly) | 0.231034 |
PE Ratio (TTM) | 13.644068 |
EPS (TTM) | 0.06 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
B3P.MU Valuation Measures
Enterprise Value | 1.13B EUR |
Trailing P/E | 13.644068 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.287521 |
Price/Book (mrq) | 0.7938856 |
Enterprise Value/Revenue | 5.19 |
Enterprise Value/EBITDA | N/A |
Trading Information
BioPharma Credit PLC Stock Price History
Beta (5Y Monthly) | 0.231034 |
52-Week Change | N/A |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.81 EUR |
52 Week Low | 0.81 EUR |
50-Day Moving Average | N/A |
200-Day Moving Average | N/A |
B3P.MU Share Statistics
Avg. Volume (3 month) | N/A |
Avg. Daily Volume (10-Days) | N/A |
Shares Outstanding | 914.25M |
Float | 1.13B |
Short Ratio | N/A |
% Held by Insiders | 7.69% |
% Held by Institutions | 39.21% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.07 |
Trailing Annual Dividend Yield | 8.53% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 83.56% |
Operating Margin (ttm) | 83.57% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | 8.33% |
Return on Equity (ttm) | 13.49% |
Income Statement
Revenue (ttm) | 218.17M EUR |
Revenue Per Share (ttm) | 0.16 EUR |
Quarterly Revenue Growth (yoy) | 174.10% |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | 182.31M EUR |
Diluted EPS (ttm) | 0.059 |
Quarterly Earnings Growth (yoy) | 180.40% |
Balance Sheet
Total Cash (mrq) | 120.53M EUR |
Total Cash Per Share (mrq) | 0.09 EUR |
Total Debt (mrq) | 0 EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 5.337 |
Book Value Per Share (mrq) | 1.014 |
Cash Flow Statement
Operating Cash Flow (ttm) | 184.28M EUR |
Levered Free Cash Flow (ttm) | 124.09M EUR |
Profile of BioPharma Credit PLC
Country | Germany |
State | N/A |
City | London |
Address | 65 Gresham Street |
ZIP | EC2V 7NQ |
Phone | N/A |
Website | https://www.bpcruk.com |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Q&A For BioPharma Credit PLC Stock
What is a current B3P.MU stock price?
BioPharma Credit PLC B3P.MU stock price today per share is 0.75 EUR.
How to purchase BioPharma Credit PLC stock?
You can buy B3P.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioPharma Credit PLC?
The stock symbol or ticker of BioPharma Credit PLC is B3P.MU.
How many shares does BioPharma Credit PLC have in circulation?
The max supply of BioPharma Credit PLC shares is 1.43B.
What is BioPharma Credit PLC Price to Earnings Ratio (PE Ratio)?
BioPharma Credit PLC PE Ratio is 12.71186400 now.
What was BioPharma Credit PLC earnings per share over the trailing 12 months (TTM)?
BioPharma Credit PLC EPS is 0.06 EUR over the trailing 12 months.